BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11241252)

  • 1. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate.
    Garbisa S; Sartor L; Biggin S; Salvato B; Benelli R; Albini A
    Cancer; 2001 Feb; 91(4):822-32. PubMed ID: 11241252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
    Ho YC; Yang SF; Peng CY; Chou MY; Chang YC
    J Oral Pathol Med; 2007 Nov; 36(10):588-93. PubMed ID: 17944751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells.
    Annabi B; Lachambre MP; Bousquet-Gagnon N; Page M; Gingras D; Beliveau R
    Biochim Biophys Acta; 2002 Jan; 1542(1-3):209-20. PubMed ID: 11853893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model.
    Sartor L; Pezzato E; Donà M; Dell'Aica I; Calabrese F; Morini M; Albini A; Garbisa S
    Int J Cancer; 2004 Dec; 112(5):823-9. PubMed ID: 15386368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion.
    Cheng XW; Kuzuya M; Nakamura K; Liu Z; Di Q; Hasegawa J; Iwata M; Murohara T; Yokota M; Iguchi A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1864-70. PubMed ID: 16051878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Albini A; Nicotra MR; Natali PG; Bagnato A
    Mol Cancer Ther; 2006 Jun; 5(6):1483-92. PubMed ID: 16818507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)Epigallocatechin-3-gallate directly inhibits MT1-MMP activity, leading to accumulation of nonactivated MMP-2 at the cell surface.
    Dell'Aica I; Donà M; Sartor L; Pezzato E; Garbisa S
    Lab Invest; 2002 Dec; 82(12):1685-93. PubMed ID: 12480918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier.
    Maeda K; Kuzuya M; Cheng XW; Asai T; Kanda S; Tamaya-Mori N; Sasaki T; Shibata T; Iguchi A
    Atherosclerosis; 2003 Jan; 166(1):23-30. PubMed ID: 12482547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
    Maeda-Yamamoto M; Suzuki N; Sawai Y; Miyase T; Sano M; Hashimoto-Ohta A; Isemura M
    J Agric Food Chem; 2003 Mar; 51(7):1858-63. PubMed ID: 12643642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical evidence for differential gallated green tea catechins binding to membrane type-1 matrix metalloproteinase and its interactors.
    Djerir D; Iddir M; Bourgault S; Lamy S; Annabi B
    Biophys Chem; 2018 Mar; 234():34-41. PubMed ID: 29407769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP.
    Oku N; Matsukawa M; Yamakawa S; Asai T; Yahara S; Hashimoto F; Akizawa T
    Biol Pharm Bull; 2003 Sep; 26(9):1235-8. PubMed ID: 12951464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
    Wang YC; Bachrach U
    Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.
    Sen T; Dutta A; Chatterjee A
    Anticancer Drugs; 2010 Jul; 21(6):632-44. PubMed ID: 20527725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase inhibition by green tea catechins.
    Demeule M; Brossard M; Pagé M; Gingras D; Béliveau R
    Biochim Biophys Acta; 2000 Mar; 1478(1):51-60. PubMed ID: 10719174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation.
    Zhen MC; Huang XH; Wang Q; Sun K; Liu YJ; Li W; Zhang LJ; Cao LQ; Chen XL
    Acta Pharmacol Sin; 2006 Dec; 27(12):1600-7. PubMed ID: 17112415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
    Farabegoli F; Govoni M; Spisni E; Papi A
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression.
    El Bedoui J; Oak MH; Anglard P; Schini-Kerth VB
    Cardiovasc Res; 2005 Aug; 67(2):317-25. PubMed ID: 15885676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
    Yamakawa S; Asai T; Uchida T; Matsukawa M; Akizawa T; Oku N
    Cancer Lett; 2004 Jul; 210(1):47-55. PubMed ID: 15172120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
    Kim M; Murakami A; Kawabata K; Ohigashi H
    Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.